Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-04-25 00:00:00 ET · period of report 2022-04-21 · accession 0001209191-22-025515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-25 | 2022-04-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $34.89 | -40.0K | 431.5K | -8% | -$1.40M |
| DM | 2022-04-25 | 2022-04-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +40.0K | 461.5K | +9% | +$108.0K |
| DM | 2022-04-25 | 2022-04-21+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | -40.0K | 46.2K | -46% | -$108.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-22 | S | D | 838 | $35.15 | 431,546 | D | — | — | (F7) Represents the weighted average sale price of the shares sold from $35.04 to $35.29 per share. |
| 2 | Common | Common Stock | 2022-04-21 | S | D | 22,715 | $34.57 | 438,831 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $34.22 to $35.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7. |
| 3 | Common | Common Stock | 2022-04-22 | M | A | 10,000 | $2.70 | 441,546 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-21 | M | A | 30,000 | $2.70 | 461,546 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-22 | S | D | 9,162 | $34.54 | 432,384 | D | — | — | (F6) Represents the weighted average sale price of the shares sold from $34.04 to $35.03 per share. |
| 6 | Common | Common Stock | 2022-04-21 | S | D | 4,062 | $35.73 | 434,769 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $35.29 to $36.25 per share. |
| 7 | Common | Common Stock | 2022-04-21 | S | D | 2,220 | $36.70 | 432,549 | D | — | — | (F4) Represents the weighted average sale price of the shares sold from $36.29 to $37.08 per share. |
| 8 | Common | Common Stock | 2022-04-21 | S | D | 1,003 | $37.90 | 431,546 | D | — | — | (F5) Represents the weighted average sale price of the shares sold from $37.70 to $38.38 per share. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-04-22 | M | D | 10,000 | $2.70 | 36,246 | D | $2.70 · — to 2027-01-03 | 10,000 Common Stock | (F8) This option is fully vested. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-04-21 | M | D | 30,000 | $2.70 | 46,246 | D | $2.70 · — to 2027-01-03 | 30,000 Common Stock | (F8) This option is fully vested. |